IN150395B - - Google Patents

Info

Publication number
IN150395B
IN150395B IN830/DEL/78A IN830DE1978A IN150395B IN 150395 B IN150395 B IN 150395B IN 830DE1978 A IN830DE1978 A IN 830DE1978A IN 150395 B IN150395 B IN 150395B
Authority
IN
India
Application number
IN830/DEL/78A
Other languages
English (en)
Inventor
F Sciavolino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IN27/DEL/81A priority Critical patent/IN150407B/en
Publication of IN150395B publication Critical patent/IN150395B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN830/DEL/78A 1978-01-03 1978-11-20 IN150395B (US06265458-20010724-C00018.png)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN27/DEL/81A IN150407B (US06265458-20010724-C00018.png) 1978-01-03 1981-01-16

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86672278A 1978-01-03 1978-01-03
US05/937,640 US4180654A (en) 1978-01-03 1978-08-29 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate

Publications (1)

Publication Number Publication Date
IN150395B true IN150395B (US06265458-20010724-C00018.png) 1982-09-25

Family

ID=27127966

Family Applications (1)

Application Number Title Priority Date Filing Date
IN830/DEL/78A IN150395B (US06265458-20010724-C00018.png) 1978-01-03 1978-11-20

Country Status (28)

Country Link
US (1) US4180654A (US06265458-20010724-C00018.png)
JP (1) JPS5495585A (US06265458-20010724-C00018.png)
AT (1) AT364457B (US06265458-20010724-C00018.png)
AU (1) AU506684B2 (US06265458-20010724-C00018.png)
CH (1) CH639972A5 (US06265458-20010724-C00018.png)
CS (1) CS204042B2 (US06265458-20010724-C00018.png)
DD (1) DD141026A5 (US06265458-20010724-C00018.png)
DE (2) DE2900118A1 (US06265458-20010724-C00018.png)
DK (1) DK147943C (US06265458-20010724-C00018.png)
ES (2) ES476544A1 (US06265458-20010724-C00018.png)
FI (1) FI68058C (US06265458-20010724-C00018.png)
FR (1) FR2413403A1 (US06265458-20010724-C00018.png)
GB (1) GB2013181B (US06265458-20010724-C00018.png)
GR (1) GR72779B (US06265458-20010724-C00018.png)
HU (1) HU180276B (US06265458-20010724-C00018.png)
IE (1) IE47642B1 (US06265458-20010724-C00018.png)
IL (1) IL56363A (US06265458-20010724-C00018.png)
IN (1) IN150395B (US06265458-20010724-C00018.png)
IT (1) IT1109925B (US06265458-20010724-C00018.png)
LU (1) LU80747A1 (US06265458-20010724-C00018.png)
NL (1) NL176461C (US06265458-20010724-C00018.png)
NO (2) NO146711C (US06265458-20010724-C00018.png)
NZ (1) NZ189274A (US06265458-20010724-C00018.png)
PH (4) PH14745A (US06265458-20010724-C00018.png)
PL (2) PL117603B1 (US06265458-20010724-C00018.png)
PT (1) PT69014A (US06265458-20010724-C00018.png)
SE (2) SE447118B (US06265458-20010724-C00018.png)
YU (2) YU312278A (US06265458-20010724-C00018.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6211669Y2 (US06265458-20010724-C00018.png) * 1980-10-06 1987-03-19
JPS5848285U (ja) * 1981-09-26 1983-04-01 コナミ工業株式会社 テ−ブル型テレビゲ−ム機
US4429116A (en) * 1982-12-27 1984-01-31 Pfizer Inc. Alkylated oleandomycin containing compounds
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
JPS62240086A (ja) * 1986-04-12 1987-10-20 株式会社 エ−ス電研 遊技機の前面構造
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
YU55690A (en) * 1990-03-21 1990-12-31 Pliva Pharm & Chem Works Process for preparing oleandomycin oxime
CL2004001012A1 (es) * 2003-05-13 2005-03-18 Glaxo Group Ltd Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310992D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869445A (en) * 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3884902A (en) * 1973-05-04 1975-05-20 Abbott Lab Sulfonyl derivatives of erythromycin
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
IE44509B1 (en) * 1976-03-03 1981-12-30 Pfizer Semi-synthetic oleandomycins
US4085119A (en) * 1977-02-04 1978-04-18 Pfizer Inc. 4-Substituted amino derivatives of oleandomycin
US4090017A (en) * 1977-02-04 1978-05-16 Pfizer Inc. 4-Deoxy-4-substituted amino derivatives of oleandomycin

Also Published As

Publication number Publication date
GB2013181B (en) 1982-06-03
GB2013181A (en) 1979-08-08
AU4298578A (en) 1979-07-12
NO146711B (no) 1982-08-16
US4180654A (en) 1979-12-25
NL7900006A (nl) 1979-07-05
YU312278A (en) 1983-01-21
NO790006L (no) 1979-07-04
PH14745A (en) 1981-11-20
PL117603B1 (en) 1981-08-31
CH639972A5 (de) 1983-12-15
PH15752A (en) 1983-03-18
IE47642B1 (en) 1984-05-16
DE2900118C2 (US06265458-20010724-C00018.png) 1987-09-17
DK147943B (da) 1985-01-14
IE790005L (en) 1979-07-03
FI68058B (fi) 1985-03-29
AU506684B2 (en) 1980-01-17
IT7919013A0 (it) 1979-01-02
NL176461C (nl) 1985-04-16
SE447118B (sv) 1986-10-27
SE448385B (sv) 1987-02-16
PL212593A1 (pl) 1979-08-27
GR72779B (US06265458-20010724-C00018.png) 1983-12-05
ATA2979A (de) 1981-03-15
CS204042B2 (en) 1981-03-31
DE2900118A1 (de) 1979-07-05
DK147943C (da) 1985-08-05
JPS5495585A (en) 1979-07-28
NZ189274A (en) 1982-03-23
PH15439A (en) 1983-01-18
NO146711C (no) 1982-11-24
NO147716B (no) 1983-02-21
AT364457B (de) 1981-10-27
FR2413403A1 (fr) 1979-07-27
SE8304417D0 (sv) 1983-08-15
ES476544A1 (es) 1979-12-01
IL56363A (en) 1982-12-31
NO147716C (no) 1983-06-01
DK507778A (da) 1979-07-04
FI790004A (fi) 1979-07-04
FI68058C (fi) 1985-07-10
JPS5734280B2 (US06265458-20010724-C00018.png) 1982-07-22
PH15626A (en) 1983-03-11
NO820613L (no) 1979-07-04
ES482420A1 (es) 1980-09-01
FR2413403B1 (US06265458-20010724-C00018.png) 1982-07-23
HU180276B (en) 1983-02-28
DE2953969C2 (US06265458-20010724-C00018.png) 1987-09-03
IT1109925B (it) 1985-12-23
SE8304417L (sv) 1983-08-15
DD141026A5 (de) 1980-04-09
PL118573B1 (en) 1981-10-31
YU213982A (en) 1983-02-28
SE7900028L (sv) 1979-07-04
LU80747A1 (fr) 1979-09-07
PT69014A (en) 1979-02-01
IL56363A0 (en) 1979-03-12

Similar Documents

Publication Publication Date Title
FR2415831B1 (US06265458-20010724-C00018.png)
FR2415284B1 (US06265458-20010724-C00018.png)
FR2415657B1 (US06265458-20010724-C00018.png)
FR2416556B1 (US06265458-20010724-C00018.png)
FR2416399B3 (US06265458-20010724-C00018.png)
FR2416183B1 (US06265458-20010724-C00018.png)
DE2825833C3 (US06265458-20010724-C00018.png)
FR2415544B1 (US06265458-20010724-C00018.png)
FR2414751B1 (US06265458-20010724-C00018.png)
FR2413403B1 (US06265458-20010724-C00018.png)
FR2416967B2 (US06265458-20010724-C00018.png)
FR2416301B3 (US06265458-20010724-C00018.png)
AU3898778A (US06265458-20010724-C00018.png)
DK141560C (US06265458-20010724-C00018.png)
AU73950S (US06265458-20010724-C00018.png)
BG26412A1 (US06265458-20010724-C00018.png)
BG25836A1 (US06265458-20010724-C00018.png)
BG25854A1 (US06265458-20010724-C00018.png)
BG25857A1 (US06265458-20010724-C00018.png)
BG27025A1 (US06265458-20010724-C00018.png)
BG25849A1 (US06265458-20010724-C00018.png)
BG26006A1 (US06265458-20010724-C00018.png)
BG26165A2 (US06265458-20010724-C00018.png)
BG25843A1 (US06265458-20010724-C00018.png)
BG26017A1 (US06265458-20010724-C00018.png)